141 related articles for article (PubMed ID: 27892790)
1. LINE-1 methylation status in prostate cancer and non-neoplastic tissue adjacent to tumor in association with mortality.
Fiano V; Zugna D; Grasso C; Trevisan M; Delsedime L; Molinaro L; Gillio-Tos A; Merletti F; Richiardi L
Epigenetics; 2017 Jan; 12(1):11-18. PubMed ID: 27892790
[TBL] [Abstract][Full Text] [Related]
2. Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer.
Richiardi L; Fiano V; Grasso C; Zugna D; Delsedime L; Gillio-Tos A; Merletti F
PLoS One; 2013; 8(7):e68162. PubMed ID: 23874531
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
[TBL] [Abstract][Full Text] [Related]
4. DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships.
Gillio-Tos A; Fiano V; Zugna D; Vizzini L; Pearce N; Delsedime L; Merletti F; Richiardi L
Cancer Causes Control; 2012 Sep; 23(9):1549-55. PubMed ID: 22810147
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.
Barry KH; Moore LE; Liao LM; Huang WY; Andreotti G; Poulin M; Berndt SI
Prostate; 2015 Nov; 75(15):1718-25. PubMed ID: 26250474
[TBL] [Abstract][Full Text] [Related]
7. Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy.
Zelic R; Fiano V; Zugna D; Grasso C; Delsedime L; Daniele L; Galliano D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Clin Cancer Res; 2016 Feb; 22(4):984-92. PubMed ID: 26475336
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
9. Global DNA hypomethylation in prostate cancer development and progression: a systematic review.
Zelic R; Fiano V; Grasso C; Zugna D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):1-12. PubMed ID: 25384337
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
[TBL] [Abstract][Full Text] [Related]
11. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
[TBL] [Abstract][Full Text] [Related]
13. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
14. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
[TBL] [Abstract][Full Text] [Related]
15. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
[TBL] [Abstract][Full Text] [Related]
16. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
[TBL] [Abstract][Full Text] [Related]
17. Selective changes of retroelement expression in human prostate cancer.
Goering W; Ribarska T; Schulz WA
Carcinogenesis; 2011 Oct; 32(10):1484-92. PubMed ID: 21828060
[TBL] [Abstract][Full Text] [Related]
18. Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer.
Sonpavde G; Aparicio AM; Zhan F; North B; Delaune R; Garbo LE; Rousey SR; Weinstein RE; Xiao L; Boehm KA; Asmar L; Fleming MT; Galsky MD; Berry WR; Von Hoff DD
Urol Oncol; 2011; 29(6):682-9. PubMed ID: 19959380
[TBL] [Abstract][Full Text] [Related]
19. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation.
Florl AR; Steinhoff C; Müller M; Seifert HH; Hader C; Engers R; Ackermann R; Schulz WA
Br J Cancer; 2004 Aug; 91(5):985-94. PubMed ID: 15292941
[TBL] [Abstract][Full Text] [Related]
20. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
